CAH Stock Price Prediction
Cardinal Health Inc
Based on 24/7 Wall St.'s proprietary analysis, we are setting a target price of $254.84 for Cardinal Health Inc (CAH) over the next 12 months. This target price suggests a 30.53% upside from the current price of $195.24. In an optimistic scenario, CAH could reach as high as $264.60, while our conservative scenario places the floor at $215.28. Wall Street analyst sentiment shows 13 Buy, 4 Hold, and 0 Sell ratings from 17 analysts covering the stock.
Current Price
$195.24
Target Price
$254.84
Optimistic Scenario
$264.60
Conservative Scenario
$215.28
The Bottom Line
Cardinal Health Inc appears attractively valued at current levels. With a 30.5% upside to our $254.84 target, the risk-reward profile looks favorable for investors with a 12-month time horizon. Wall Street agrees, with 76% of analysts rating it a Buy.
12-Month Price Scenarios
Where CAH could be in one year
This chart shows three potential price paths for CAH over the next 12 months: our Target Price, an Optimistic Scenario, and a Conservative Scenario. Learn how we calculate our price targets →
Loading chart...
Catalysts
Factors that could drive upside
In our optimistic scenario, CAH could reach $264.60 (+35.5% from current price). Key catalysts include:
- Better-than-expected earnings results
- Favorable sector and market conditions
- Positive analyst revisions or upgrades
Risks
Factors that could limit upside
In our conservative scenario, CAH could fall to $215.28 (10.3% from current price). Key risks include:
- Earnings misses or guidance cuts
- Broader market or economic headwinds
- Increased competition or margin pressure
Analyst Sentiment
17 analysts covering CAH
The 24/7 Factor
Our proprietary price adjustment model
24/7 Wall St.'s stock forecasts utilize a number of factor adjustments that either increase or decrease a stock's 12-month price target. Toggle the factors our model uses on or off below to see how each impacts CAH's share price.
Our Adjustment
1.166×
Adjusted Target
$254.84
Factor Components Toggle to simulate
5-Year Price Projection
Long-term quarterly forecast through 2031
Optimistic Scenario
$402.60
+106.2%
Target Price
$419.08
+114.7%
Conservative Scenario
$267.19
+36.9%
Long-term projections factor in increased uncertainty over time.
Frequently Asked Questions
CAH stock price predictions and forecasts
What is the CAH stock price prediction for 2030?
Looking ahead to 2030, our model projects CAH could trade at an average price of $359.71, with a potential range between $269.78 and $449.64. This represents a potential 84.2% return from today's price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.
Is CAH a buy, sell, or hold right now?
24/7 Wall St. currently rates CAH as a BUY. Strong upside (+30.5%) Among Wall Street analysts, 13 rate it Buy, 4 rate it Hold, and 0 rate it Sell.
What is the CAH stock price target in an optimistic scenario?
In our optimistic scenario for CAH, the stock could reach $264.60 over the next 12 months, representing a 35.5% gain from today's price. This scenario assumes favorable conditions materialize, including strong earnings growth, positive market sentiment, and successful execution of company initiatives.
What is the downside risk for CAH stock?
Even in our conservative scenario, CAH is projected at $215.28 over the next 12 months — roughly flat or slightly higher than today's price. This suggests limited downside risk at current valuations, though unexpected headwinds could still impact the stock.
How accurate are CAH stock price predictions?
Stock price predictions are forward-looking estimates, not guarantees. Our model for CAH incorporates analyst consensus, valuation metrics, technical indicators, and market sentiment. However, actual stock performance depends on many unpredictable factors including earnings surprises, macroeconomic changes, and market psychology. We provide optimistic and conservative scenarios alongside our target price to illustrate the range of potential outcomes. Always conduct your own research before investing.